Advertisement
The leading life science news channel in the Nordic region.
Collaboration - November 26, 2024
Danish and Swedish life science strategies under the lens at Medicon Valley Alliance Annual Meeting.
Biotech Business - November 25, 2024
During the World AMR Awareness Week (WAAW) NLS has chosen to highlight different Nordic companies and investors sharing what part of the solution they bring to the table and how their impact can be leveraged globally.
Biotech Business - November 25, 2024
BICO has entered into an agreement to divest Nanoscribe to LAB14 GmbH to an equity value of EUR 26 million.
Biotech Business - November 21, 2024
During the World AMR Awareness Week (WAAW) NLS has chosen to highlight different Nordic companies and investors sharing what part of the solution they bring to the table and how their impact can be leveraged globally.
Biotech Business - November 20, 2024
During the World AMR Awareness Week (WAAW) NLS has chosen to highlight different Nordic companies and investors sharing what part of the solution they bring to the table and how their impact can be leveraged globally.
In a new job - November 20, 2024
The company has also announced a reduction in workforce and management layers to improve efficiency and reduce costs.
Financing - November 20, 2024
All over the Nordics, the innovative power is gearing up to put new products, therapies and preventive measures on the market that all help tackle AMR from various angles.
Biotech Business - November 20, 2024
Xbrane Biopharma and Intas Pharmaceuticals have announced an exclusive global licensing and co-development agreement for Xbrane´s Nivolumab Biosimilar candidate (referencing Opdivo).
Clinical Trials - November 19, 2024
Modus Therapeutics has received approval from the relevant authorities in Italy for its planned Phase IIa clinical trial with sevuparin.
Biotech Business - November 19, 2024
In the cross-border region Medicon Valley, a new alliance is forming to highlight not just the global challenge that antimicrobial resistance (AMR) poses but the range of solutions being developed in the life science sector.
This site uses cookies